Haisco Pharmaceutical Group Co Ltd (002653):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Haisco Pharmaceutical Group Co Ltd (002653) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8238
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive system drugs and tumor adjuvant drugs. Its parenteral nutrition drugs include compound amino acid injection, injectable fat-soluble vitamins, vitamin and trace element drug, invert sugar injection, trace element injection and injectable fat soluble vitamins. Haisco Pharma’s first-aid drugs comprise cefotene hydrochloride, sodium fusidate, cefmetazole sodium, cefmenoxime hydrochloride and cefoperazone sodium tazobactam sodium. The company conducts research and development of drugs in monoclonal antibodies for anticancer, small molecular patent medicine and novel generic drugs. It operates offices in Shannan and Chengdu, China. Haisco Pharma is headquartered in Shannan, China.

Haisco Pharmaceutical Group Co Ltd (002653) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 12
Partnerships 14
Haisco Pharma Plans to Form Tibetan Medicine R&D Company Joint Venture 14
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 15
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 16
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 17
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 18
Microbion Enters into Agreement with Xizang Haisco Pharma 19
Equity Offering 20
Microbion Raises Funds through Private Placement of Shares 20
Xizang Haisco Pharma Completes IPO For US$127 Million 21
Debt Offering 22
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 22
Acquisition 23
Haisco Pharma to Acquire 60.67% Stake in Fronthera 23
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 24
Haisco Pharmaceutical Group Co Ltd – Key Competitors 25
Haisco Pharmaceutical Group Co Ltd – Key Employees 26
Haisco Pharmaceutical Group Co Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 12
Haisco Pharma Plans to Form Tibetan Medicine R&D Company Joint Venture 14
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 15
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 16
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 17
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 18
Microbion Enters into Agreement with Xizang Haisco Pharma 19
Microbion Raises Funds through Private Placement of Shares 20
Xizang Haisco Pharma Completes IPO For US$127 Million 21
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 22
Haisco Pharma to Acquire 60.67% Stake in Fronthera 23
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 24
Haisco Pharmaceutical Group Co Ltd, Key Competitors 25
Haisco Pharmaceutical Group Co Ltd, Key Employees 26
Haisco Pharmaceutical Group Co Ltd, Other Locations 27
Haisco Pharmaceutical Group Co Ltd, Subsidiaries 27

List of Figures
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Haisco Pharmaceutical Group Co Ltd (002653):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stellar Biotechnologies Inc (SBOT)-医療機器分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Rosneft Oil Co (ROSN):電力:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • San Miguel Brewery Hong Kong Ltd.
    San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Softship AG:企業の戦略的SWOT分析
    Softship AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tesaro Inc (TSRO)-製薬・医療分野:企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • Midwest Energy Cooperative:企業の戦略的SWOT分析
    Midwest Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AusGroup Ltd (5GJ):石油・ガス:M&Aディール及び事業提携情報
    Summary AusGroup Ltd (AusGroup) is a provider of project and asset services. The company operates through its subsidiaries, namely, MAS, AGC, and NT Port and Marine. Its major services include mechanical and piping, scaffolding, multidisciplinary maintenance services, fabrication & management, surfa …
  • Ellie Mae Inc (ELLI):企業の財務・戦略的SWOT分析
    Summary Ellie Mae Inc (Ellie Mae) is a technology company that provides cloud-based technology solutions, online network, software and services for the residential mortgage industry. It offers network applications that enable mortgage originators such as mortgage bankers and mortgage brokers, commun …
  • Thomas & Betts Corp:企業の戦略的SWOT分析
    Thomas & Betts Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Apache Corporation:戦略・SWOT・企業財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Medidata Solutions Inc (MDSO):製薬・医療:M&Aディール及び事業提携情報
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data and analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data ana …
  • Northland Power Inc (NPI):電力:M&Aディール及び事業提携情報
    Summary Northland Power Inc. (Northland Power) is an independent power producer that develops, finances, builds, owns, and operates clean and green power projects in Canada and internationally. The company generates energy from natural gas, biomass, landfill gas, wind and solar sources. In thermal g …
  • China Haisheng Juice Holdings Co Ltd:戦略・SWOT・企業財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Orcas Power & Light Cooperative:企業の戦略的SWOT分析
    Orcas Power & Light Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Rockwell Automation Inc (ROK):石油・ガス:M&Aディール及び事業提携情報
    Summary Rockwell Automation Inc (Rockwell) is a provider of industrial automation power, control and information systems. The company offers connected components, midrange architecture system, asset and consultancy management; engineered packages and panels integration; front end engineering and des …
  • Cracker Barrel Old Country Store, Inc. (CBRL):企業の財務・戦略的SWOT分析
    Cracker Barrel Old Country Store, Inc. (CBRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Hess Corporation:企業の戦略・SWOT・財務情報
    Hess Corporation - Strategy, SWOT and Corporate Finance Report Summary Hess Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Gulf Holding Company:企業の戦略的SWOT分析
    Gulf Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆